Skip to main content
SpringerLink
Log in

Myocardial Protection Using Nucleoside Transport Inhibitors

  • Chapter
Purines and Myocardial Protection

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 181))

Abstract

This chapter will consider endogenous adenosine in the protection of the ischemic myocardium, the role of nucleoside transport inhibition in enhancing this protection, and the likely application of nucleoside transport inhibitors in clinical cardiovascular therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation 1992;85:93–904.

    Google Scholar 

  2. Van Belle H. Specific metabolically active antiischemic agents: adenosine and nuleoside transport inhibitors. Singh B, Dzau V, Vanhoutte P and Woosley R, editors. Cardiovascular Pharmacology and Therapeutics, Churchill Livingstone, NY, 1993;217–235.

    Google Scholar 

  3. Pepine CJ. New insights in measurement of myocardial ischemia. Am J Cardiol 1992;70:199–259.

    Article  Google Scholar 

  4. Lawson CS, Downey JM. Preconditioning: state of the art myocardial protection. Cardiovasc. Res., 1993;27:542–550.

    Article  PubMed  CAS  Google Scholar 

  5. Forman MB, Velasco CE, Jackson EK. Adenosine attenuates reperfusion injury following regional myocardial ischemia. Cardiovasc Res 1993;127:9–17.

    Article  Google Scholar 

  6. Gruber HE, Hoffer ME, McAllister DR, Laikind PK, Lane TA, Schmid-Schoenbein GW, Engler RL. Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury. Circulation 1989;10:1400–1411.

    Article  Google Scholar 

  7. Van Belle H. Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine? Cardiovasc Res 1993;27:68–76.

    Article  PubMed  Google Scholar 

  8. Van Belle H, Janssen PAJ. Comparative pharmacology of nucleoside transport inhibitors. Nucleosides & Nucleotides 1991;10:975–982.

    Article  Google Scholar 

  9. Sanz G, Pajaron A, Alegría E, Coello I, Cardona M, et al. (GESIC). Prevention of early aortocornary bypass occlusion by low-dose aspirin and dipyridamole. Circulation 1990;82:765–773.

    Article  PubMed  CAS  Google Scholar 

  10. Cass CE, Gaudette LA, Paterson AP. Mediated transport of nucleosides in human erythrocytes: specific binding of the inhibitor nitrobenzylthioinosine to nucleoside transport sites in the erythrocyte membrane. Biochim Biophys Acta 1974;345:1–10.

    Article  PubMed  CAS  Google Scholar 

  11. Abd-Elfattah AS, Jessen ME, Hannan SA, Tuchy G, Wechsler AS. Is adenosine 5′-triphosphate derangement or free-radical-mediated injury the major cause of ventricular dysfunction during reperfusion? Circulation 1990;82(suppl. IV):341–350.

    Google Scholar 

  12. Abd-Elfattah AS, Ding M, Dyke CM, Wechsler AS. Protection of the stunned myocardium. Circulation 1993;88:336–343.

    CAS  Google Scholar 

  13. Van Belle H. The disappearance of adenosine in blood. Effect of lidoflazine and other drugs. Eur J Pharmacol 1970;11:241–248.

    Article  PubMed  Google Scholar 

  14. Van Belle H, Verheyen W, Ver Donck K, Janssen PAJ, Robertson JIS. Prevention of catecholamine-induced cardiac damage and death with a nucleoside transport inhibitor. J Cardiovasc Pharmacol 1992;20:173–178.

    Article  PubMed  Google Scholar 

  15. Dennis D, Martens J, Bellardinelli L. Frequency-dependent negative dromotropic effect of adenosine metabolism inhibitors in guinea pig heart. Drug Dev Res 1994;31:263 (Abstr).

    Google Scholar 

  16. Masuda M, Demeulemeester A, Chang-Chun C, Hendrikx M, Van Belle H, Flameng W. Cardioprotective effects of nucleoside transport inhibition in rabbit hearts. Ann Thorac Surg 1991;52:1300–1305.

    Article  PubMed  CAS  Google Scholar 

  17. Van Belle H, Goossens F, Wynants J. Biochemical and functional effects of nucleoside transport inhibition in the isolated cat heart. J Mol Cell Cardiol 1989;21:797–805.

    Article  PubMed  Google Scholar 

  18. Masuda M, Chang-Chun C, Möllhoff T, Van Belle H, Flameng W. Effects of nucleoside transport inhibition on long-term ex vivo preservation of canine hearts. J Thorac Cardiovasc Surg 1992;104,1610–1617.

    PubMed  CAS  Google Scholar 

  19. Flameng W, Sukehiro S, Möllhoff T, Van Belle H, Janssen PAJ. A new concept of long-term donor heart preservation: nucleoside transport inhibition. J Heart and Lung Transplant 1992;10:990–998.

    Google Scholar 

  20. Vandeplassche G, Hermans C, D’Aubioul J, Van Belle H. Effect of nucleoside transport inhibition on the contractile function of stunned myocardium. Circulation 1991;84(Suppl II):A2607.

    Google Scholar 

  21. Itoya M, Miura T, Urabe K, Ishimoto R, Iimura O. Nucleoside transport inhibitors enhanced the infarct size-limiting effect of preconditioning. Circulation 1992;86(Suppl. I):I–25.

    Google Scholar 

  22. Wainwright CL, Parratt JR, Van Belle H. The antiarrhythmic effects of the nucleoside transport inhibitor, R 75231, in anaesthetised pigs. Br J Pharmacol 1993;109:592–599.

    PubMed  CAS  Google Scholar 

  23. Kirkebøen K, Illebekk A, Tønessen T, Leistad E, Naes PA, Christensen G, Aksness G. Cardiac contractile function following repetitive brief ischemia: effects of nucleoside transport inhibition. Am J Physiol 1994;267;H57–H65.

    PubMed  Google Scholar 

  24. De Haan HH, De Haan J, Van Reempts JLH, Van Belle H, Hasaart THM. The effect of adenosine transport inhibition on cardiovascular function and survival after severe asphyxia in fetal lambs. Pediatr Res 1993;33:185–189.

    Article  PubMed  Google Scholar 

  25. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomized trials of antiplatelet therapy — I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308:81–106.

    Google Scholar 

  26. Shepard LY. The competitive market for antiplatelets and thrombolytics: can a new entrant succeed? TIBTECH 1991;80–85.

    Google Scholar 

  27. Hernandez R, Alemany M, Bozzo J, Buchanan MR, Ordinas A, Bastida E. Platelet adhesivity to subendothelium is influenced by polymorphonuclear leukocytes: studies with aspirin and salicylate. Haemostasis 1993;23:1–7.

    PubMed  CAS  Google Scholar 

  28. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 1994;76:5–13.

    PubMed  CAS  Google Scholar 

  29. Nolte D, Lehr HA, Messmer K. Adenosine inhibits postishemic leukocyte-endothelium interaction in postcapillary venules of the hamster. Am J Physiol 1991;261:H651–H655.

    PubMed  CAS  Google Scholar 

  30. de la Harpe J, Nathan CF. Adenosine regulates the respiratory burst of cytokine-triggered human neutrophils adherent to biologic surfaces. J Immunol 1989;143:596–602.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Janssen Research Foundation, B-2340, Beerse, Belgium

    Herman Van Belle (Director Scientific Support)

Authors
  1. Herman Van Belle
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cardiothoracic Division, Department of Surgery, Box 890532, MCV Station, Richmond, VA, 23298-0532, USA

    Anwar-Saad A. Abd-Elfattah MS, Ph.D.

  2. Department of Surgery, Medical College of Virginia, Richmond, Virginia, 23298-0532, USA

    Andrew S. Wechsler M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Kluwer Academic Publishers

About this chapter

Cite this chapter

Van Belle, H. (1996). Myocardial Protection Using Nucleoside Transport Inhibitors. In: Abd-Elfattah, AS.A., Wechsler, A.S. (eds) Purines and Myocardial Protection. Developments in Cardiovascular Medicine, vol 181. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0455-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0455-5_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-8056-6

  • Online ISBN: 978-1-4613-0455-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation